Beximco Pharmaceuticals Limited
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Beximco Pharmaceuticals Limited's balance sheet done over the years? Its assets were worth $69,344,022,640 last year, which is more than in the previous period. 25% of Beximco Pharmaceuticals Limited’s total assets is currently financed by debt. Its liabilities reached the amount of $17,441,119,760, which means an decrease by -19% compared compared to last year.
Debt to Assets
| 2012 | 24589810592 | 6.18B | 25.14% |
|---|---|---|---|
| 2013 | 27470751802 | 7.69B | 28.01% |
| 2014 | 29000525961 | 8.08B | 27.86% |
| 2015 | 30835550584 | 8.35B | 27.1% |
| 2018 | 43738886412 | 16.38B | 37.47% |
| 2019 | 49214092360 | 19.34B | 39.32% |
| 2020 | 50118741940 | 17.32B | 34.56% |
| 2021 | 52246084026 | 14.88B | 28.48% |
| 2022 | 66148035742 | 21.51B | 32.52% |
| 2024 | 69344022640 | 17.44B | 25.15% |
BXP.L Balance Sheet (2013 – 2023)
| 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 854.10M | 1.16B | 675.46M | 635.01M | 610.49M | 393.73M | 147.47M | 222.23M | 595.73M | 552.97M |
Short term investments | 200M | 108.07M | 112.82M | 70.79M | 323.36M | 339.39M | 1.53B | 2.47B | 3.02B | 2.68B |
Net receivables | 0 | -11.12B | 4.50B | 3.08B | 3.24B | 2.76B | 1.59B | 1.39B | 0 | 0 |
Inventory | 13.01B | 11.12B | 7.80B | 6.72B | 6.65B | 5.72B | 3.37B | 3.04B | 2.84B | 2.83B |
Other current assets | 6.74B | 17.25B | 788.81M | 751.15M | 1.78B | 1.32B | 1.73B | 1.16B | 2.43B | 2.12B |
Total current assets | 20.81B | 18.41B | 13.77B | 13.04B | 13.26B | 11.34B | 8.39B | 8.36B | 8.90B | 8.19B |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 43.04B | 42.37B | 36.53B | 35.24B | 34.05B | 30.52B | 22.16B | 20.39B | 18.36B | 16.20B |
Goodwill | 674.57M | 674.57M | 546.69M | 546.69M | 546.69M | 546.69M | 0 | 0 | 0 | 0 |
Intangible assets | 4.72B | 4.56B | 1.38B | 1.27B | 1.33B | 1.28B | 269.86M | 235.20M | 198.22M | 187.07M |
Long term investments | -179.02M | 23.35M | 16.59M | 3.75M | -318.03M | -302.88M | -1.53B | -2.46B | -3.02B | -2.68B |
Other non-current assets | 200M | 0 | 16.59M | 6.43M | 6.32M | 6.09M | 1.53B | 2.47B | 3.02B | 2.68B |
Total non-current assets | 48.52B | 47.72B | 38.47B | 37.06B | 35.94B | 32.39B | 22.44B | 20.63B | 18.56B | 16.39B |
Total assets | 69.34B | 66.14B | 52.24B | 50.11B | 49.21B | 43.73B | 30.83B | 29.00B | 27.47B | 24.58B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 0 | 368.43M | 0 | 0 | 433.41M | 328.19M | 212.64M | 65.91M | -55.37M |
Short term debt | 2.99B | 8.91B | 6.42B | 8.85B | 10.88B | 7.16B | 4.04B | 3.81B | 3.53B | 2.19B |
Total current liabilities | 9.56B | 12.73B | 9.34B | 11.35B | 12.74B | 9.01B | 4.86B | 4.70B | 4.38B | 3.06B |
| Non-current liabilities: | ||||||||||
Long term debt | 0 | 3.45B | 1.20B | 1.65B | 2.59B | 4.01B | 1.32B | 901.70M | 1.15B | 1.46B |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 5.30B | 2.78B | 234.02M | 2.14B | 1.86B | 1.32B | 451.85M | 2.47B | 610.62M | 499.62M |
Total non-current liabilities | 7.87B | 8.77B | 5.53B | 5.96B | 6.60B | 7.36B | 3.49B | 3.37B | 3.31B | 3.11B |
Total liabilities | 17.44B | 21.51B | 14.88B | 17.32B | 19.34B | 16.38B | 8.35B | 8.08B | 7.69B | 6.18B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |